Agrochemicals company Insecticides (India) announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenue from Operations: Rs 358.92 crore in Q4FY25, showing a 32% growth compared to Rs 272.50 crore in Q4FY24. Gross Profit: Rs 131.36 crore in Q4FY25, showing a 51% growth compared to Rs 86.84 crore in Q4FY24. EBITDA: Rs 28.47 crore in Q4FY25, showing a 226% growth compared to Rs 8.73 crore in Q4FY24. EBITDA Margin (%): 7.9% in Q4FY25, compared to 3.2% in Q4FY24. Profit After Tax: Rs 13.89 crore in Q4FY25, showing an 85% growth compared to Rs 7.52 crore in Q4FY24. FY25 Financial Highlights: Revenue from Operations: Rs 1,999.95 crore in FY25, showing a 2% growth compared to Rs 1,966.39 crore in FY24. Gross Profit: Rs 640.83 crore in FY25, showing a 28% growth compared to Rs 501.36 crore in FY24. EBITDA: Rs 221.22 crore in FY25, showing a 36% growth compared to Rs 162.32 crore in FY24. EBITDA Margin (%): 11.1% in FY25, compared to 8.3% in FY24. Profit After Tax: Rs 142.02 crore in FY25, showing a 39% growth compared to Rs 102.07 crore in FY24. Commenting on the results and performance, Rajesh Kumar Aggarwal, MD of Insecticides (India) said: “We are pleased to report a robust performance of the Company, marked by strong execution and strategic discipline, resulting in a profit growth of 39% in FY25. This performance underscores the success of the strategic framework we established —centered around profitable growth, a sharper focus on premium products, and margin enhancement. The overall business environment remained favorable throughout the year. A good monsoon and healthy reservoir levels provided strong tailwinds for rural demand and agri-input consumption. Additionally, stable raw material prices and our deep farmer connect further supported steady demand across markets. Our continued focus on premiumization yielded positive results, driving an improvement in gross margins. We consciously prioritized value over volume, reflecting our long-term strategy of sustainable, profitable growth. This disciplined approach also led to an improvement in key return metrics, with both ROCE and ROE improving consistently even in FY25, a direct outcome of better product mix and efficient capital allocation. Looking ahead, we remain optimistic about the upcoming seasons. We expect continued momentum supported by favorable macro tailwinds such as a strong monsoon forecast and stable raw material prices. Our growth outlook remains intact, with expectations of expansion in premium products, stable gross profit margins, and EBITDA improvement, driven by new launches and operational efficiencies. Recently we also launched Altair, a patented pre-emergent herbicide for paddy developed by Nissan Chemical Corporation, Japan, which will be exclusively marketed by us in India. This launch is a testament of our commitment to deliver innovative and effective solutions that address the real challenges faced by Indian farmers. With a robust product pipeline and planned launches in the coming year and in recent years, we are well-positioned to capture emerging opportunities in the market. While continued investment in future majorly at Dahej capacity expansion and upgraded technical and formulation facilities at Sotanala, Rajasthan. We remain deeply committed to sustainability, innovation, and responsible growth. As we move forward, our focus stays firmly on delivering long-term value for our stakeholders, while creating a positive impact on the environment and the communities we serve. With a strong foundation and clear vision, we are confident in building a resilient, promising future for our business.” Result PDF